Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 211-215

  Archibald, Lennox ^c   Phillips, Lisa ^c   Monnet, Dominique ^a   McGowan Jr , John E ^c   Tenover, Fred ^c   Gaynes, Robert ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; IMIPENEM; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; ENTEROBACTER CLOACAE; HOSPITAL PATIENT; INTENSIVE CARE UNIT; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0031049859     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.211     Document Type: Article

References (17)

1. Bryan RT, Pinner RW, Gaynes RP, Peters CJ, Aguilar JR, Berkelman RL. Addressing emerging infectious disease threats: a prevention strategy for the United States. MMWR Morb Mortal Wkly Rep 1994;43(RR5):1-18.
2. U.S. Congress, Office of Technology Assessment. Impacts of antibiotic-resistant bacteria, OTA-H-629. Washington, DC: U.S. Government Printing Office, 1995.
3. McGowan JE Jr, Hall EC, Parrott PL. Antimicrobial susceptibility in Gram-negative bacteremia: are nosocomial isolates really more resistant? Antimicrob Agents Chemother 1989;33:1855-9.
4. Bryce EA, Smith JA. Focused microbiological surveillance and Gram-negative beta-lactamase-mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol 1995; 16:331-4.
5. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991;91(suppl 3B):S185-91.
6. Yu VL, Oakes CA, Axnick KJ, Merigan TC. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med 1979;44:468-73.
7. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant Enterococcus in New York City. Lancet 1993;342: 490-1.
8. Monnet D, Edwards J, Gaynes R, the National Nosocomial Infections Surveillance (NNIS) System. Extended spectrum beta-lactam-resistant nosocomial Klebsiella pneumoniae (ESB-KP): epidemiologic evidence of interhospital transmission [abstract no 24]. In: Program of the 4th annual meeting of the Society for Healthcare Epidemiology of America (New Orleans). Thorofare, NJ: SLACK, 1994:23.
9. Hofmann J, Cetron MS, Parley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333:481-6.
10. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
11. Layton MC, Hierholzer WJ, Patterson JE. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol 1995; 16:12-7.
12. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveillance (NNIS) system: description of surveillance methods. Am J Infect Control 1991; 19:19-35.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 3rd ed. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
14. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
15. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infections. Am J Med 1981;70:449-52.
16. Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital-acquired infections in the ICU patient. Crit Care Med 1982; 10:355-7.
17. Eickhoff TC. Antibiotics and nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, Brown & Co., 1992: 245-64.